Serina Therapeutics Correlations

SER Stock

5.22 0.43 8.98%

The current 90-days correlation between Serina Therapeutics and Lipocine is 0.24 (i.e., Modest diversification). The correlation of Serina Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Serina Therapeutics Correlation With Market

Good diversification

The correlation between Serina Therapeutics and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Serina Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Serina Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Serina Stock, please use our How to Invest in Serina Therapeutics guide.

Moving together with Serina Stock

0.79	VALN	Valneva SE ADR	Pair Corr
0.62	ERNA	Eterna Therapeutics	Pair Corr
0.79	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.84	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.67	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.82	PFE	Pfizer Inc Buyout Trend	Pair Corr
0.72	GNFT	Genfit	Pair Corr
0.71	IMAB	I Mab	Pair Corr
0.69	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.76	MRVI	Maravai Lifesciences	Pair Corr
0.76	REGN	Regeneron Pharmaceuticals	Pair Corr
0.7	AKAN	Akanda Corp	Pair Corr
0.71	AMGN	Amgen Inc	Pair Corr
0.73	ANRO	Alto Neuroscience,	Pair Corr
0.61	ARDX	Ardelyx	Pair Corr

Moving against Serina Stock

0.73	GILD	Gilead Sciences	Pair Corr
0.71	BMY	Bristol Myers Squibb	Pair Corr
0.62	DYAI	Dyadic International	Pair Corr
0.53	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.77	MNMD	Mind Medicine	Pair Corr
0.55	ABCL	Abcellera Biologics	Pair Corr
0.78	TARS	Tarsus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	LPCN	WM	APAM	SEIC	MTX	NUVL	NTGR
LPCN		0.01	0.02	0.15	0.02	-0.39	0.05	LPCN
WM	0.01		0.85	0.77	0.86	-0.52	0.77	WM
APAM	0.02	0.85		0.92	0.9	-0.59	0.92	APAM
SEIC	0.15	0.77	0.92		0.8	-0.78	0.94	SEIC
MTX	0.02	0.86	0.9	0.8		-0.51	0.77	MTX
NUVL	-0.39	-0.52	-0.59	-0.78	-0.51		-0.67	NUVL
NTGR	0.05	0.77	0.92	0.94	0.77	-0.67		NTGR
	LPCN	WM	APAM	SEIC	MTX	NUVL	NTGR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NTGR	+ 0.94	SEIC
SEIC	+ 0.92	APAM
NTGR	+ 0.92	APAM
MTX	+ 0.9	APAM
MTX	+ 0.86	WM
APAM	+ 0.85	WM

High negative correlations

NUVL	- 0.78	SEIC
NTGR	- 0.67	NUVL
NUVL	- 0.59	APAM
NUVL	- 0.52	WM
NUVL	- 0.51	MTX
NUVL	- 0.39	LPCN

Risk-Adjusted Indicators

There is a big difference between Serina Stock performing well and Serina Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Serina Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LPCN	3.38	0.25	0.04	(1.62)	4.71	(3.34)	7.08	(6.20)	24.60
WM	0.80	(0.02)	(0.05)	0.01	1.01	(0.85)	1.59	(1.75)	7.34
APAM	1.32	0.07	0.07	0.10	1.61	(1.33)	2.52	(2.85)	12.25
SEIC	0.80	0.30	0.31	0.42	0.46	(0.97)	1.57	(1.56)	7.23
MTX	1.27	0.02	0.05	0.07	1.29	(1.41)	2.46	(2.49)	11.90
NUVL	1.68	(0.43)	0.00	(0.25)	0.00	0.00	2.66	(5.51)	13.19
NTGR	1.72	0.25	0.13	0.38	1.58	(2.06)	3.92	(3.05)	11.27

Serina Therapeutics Corporate Executives

Elected by the shareholders, the Serina Therapeutics' board of directors comprises two types of representatives: Serina Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Serina. The board's role is to monitor Serina Therapeutics' management team and ensure that shareholders' interests are well served. Serina Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Serina Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

	Michael Bentley	Chief CoFounder	Profile
	Milton Harris	CoFounder Board	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC